Relmada Therapeutics
RLMD
#9903
Rank
NZ$20.3 M
Marketcap
$0.67
Share price
4.60%
Change (1 day)
-87.09%
Change (1 year)

Relmada Therapeutics (RLMD) - Cash on Hand

Cash on Hand as of September 2024 : NZ$95.92 Million

According to Relmada Therapeutics's latest financial reports the company has NZ$95.92 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Relmada Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.23 B-24.7%
2021-12-31NZ$0.31 B91.18%
2020-12-31NZ$0.16 B
2019-06-30NZ$13.71 M314.71%
2018-06-30NZ$3.3 M41.28%
2017-06-30NZ$2.34 M-80.39%
2016-06-30NZ$11.93 M-63.68%
2015-06-30NZ$32.85 M12.79%
2014-06-30NZ$29.13 M
2013-08-31NZ$0.01 M76.22%
2012-08-31NZ$0.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$1.59 B 1,567.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$1.79 B 1,769.43%๐Ÿ‡บ๐Ÿ‡ธ USA